Results 11 to 20 of about 6,862 (171)

Hepatitis C identification and treatment in rural Pennsylvania, USA

Preventive Medicine Reports, 2021
The opioid epidemic in the United States has led to increases in hepatitis C virus (HCV) infection especially in rural communities. It is recommended that persons who inject drugs undergo screening and treatment.
Tuesdae Stainbrook, Kelsey Elliott, Amy Powell, Mary A. Simpson, Maddy Bash   +4 more
doaj   +1 more source

FAAH rs324420 Polymorphism in People With Opioid and Methamphetamine Use Disorders: Psychological Associations. [PDF]

Brain Behav
This study explored the association between the FAAH rs324420 polymorphism and substance use disorders in individuals with methamphetamine, opioid, and combined use. The rs324420 CA genotype was linked to a reduced risk of substance use disorder, while higher craving scores were observed in individuals with combined opioid–methamphetamine use. ABSTRACT
Erekli-Arat Ö, Tepe M, Özkan-Kotiloğlu S, Danışman M, Kaya-Akyüzlü D.   +4 more
europepmc   +2 more sources

French Experience with Buprenorphine : Do Physicians Follow the Guidelines? [PDF]

PLoS ONE, 2015
Opiate dependence affects about 15,479,000 people worldwide. The effectiveness of opiate substitution treatments (OST) has been widely demonstrated. Buprenorphine plays a particular role in opiate dependence care provision in France.
Morgane Guillou Landreat, Charles Rozaire, Jean Yves Guillet, Caroline Victorri Vigneau, Jean Yves Le Reste, Marie Grall Bronnec   +5 more
doaj   +1 more source

High-dose intravenous hydromorphone for patients who use opioids in the hospital setting: time to reduce the barriers

Harm Reduction Journal, 2021
Individuals who use opioids have higher rates of hospitalization compared to the general population. Insufficiently treated withdrawal and pain are major factors contributing to high rates of self-initiated hospital discharges (also referred to as ...
Laura E. Labonté, Samantha Young
doaj   +1 more source

Brief report: Ketamine-assisted "bridge therapy" for opioid tapering in complex cases. [PDF]

Am J Addict
Abstract Background Opioid use disorder (OUD) presents major challenges, especially when combined with chronic pain and psychiatric comorbidities. A 25‐year‐old woman with OUD, chronic pain, and major depressive disorder underwent an 8‐week protocol of intravenous ketamine infusions (0.5 mg/kg weekly) as an adjunct to opioid tapering. Results Methadone
de Oliveira MC, de Araujo Palmeira CC, Negrão AB, Hadi ZA, Arana JR, de Cássia Ferreira Duarte R, da Silva JLP, Matsui GK, Rapozero JFD, Crispim DH, Malbergier A, Castaldelli-Maia JM.   +11 more
europepmc   +2 more sources

Centralization of the methadone maintenance plan in a hospital pharmacy department in the Community of Madrid [PDF]

Farmacia Hospitalaria, 2020
In February 2018, Resolution 189/2018 was published in the Autonomous Community of Madrid with the objective of centralizing the procedure for the acquisition, preparation, distribution, and dispensing of methadone to Centres for the Comprehensive ...
Elena Alba Álvaro-Alonso, Pilar Tejedor-Prado, Antonio Aguilar-Ros, Ismael Escobar-Rodríguez   +3 more
doaj   +1 more source

Effect of fruit smoothie supplementation on psychological distress among people with substance use disorders receiving opioid agonist therapy: protocol for a randomised controlled trial (FruktBAR)

BMC Nutrition, 2022
Background People with substance use disorders generally have unhealthy diets, including limited intake of fruit and vegetables. Evidence shows substantial health benefits from increasing fruit and vegetable consumption on various indicators and possibly
Lars T. Fadnes, Einar Furulund, Karl Trygve Druckrey-Fiskaaen, Tesfaye Madebo, Jørn Henrik Vold, Maria Olsvold, Marianne Cook Pierron, Siv-Elin Leirvåg Carlsen, Rune Blomhoff, Torgeir Gilje Lid, for the ATLAS4LAR Study Group   +10 more
doaj   +1 more source

FORWARDS-1: an adaptive, single-blind, placebo-controlled ascending dose study of acute baclofen on safety parameters in opioid dependence during methadone-maintenance treatment—a pharmacokinetic-pharmacodynamic study

Trials, 2022
Background Treatment of opiate addiction with opiate substitution treatment (e.g. methadone) is beneficial. However, some individuals desire or would benefit from abstinence but there are limited options to attenuate problems with opiate withdrawal ...
L. M. Paterson, D. Barker, S. Cro, P. Mozgunov, R. Phillips, C. Smith, L. Nahar, S. Paterson, A. R. Lingford-Hughes   +8 more
doaj   +1 more source

Mitragynine Attenuates Morphine Withdrawal Effects in Rats—A Comparison With Methadone and Buprenorphine

Frontiers in Psychiatry, 2020
BackgroundOpiate addiction is a major health problem in many countries. A crucial component of the medical treatment is the management of highly aversive opiate withdrawal signs, which may otherwise lead to resumption of drug taking.
Rahimah Hassan, Cheah Pike See, Sasidharan Sreenivasan, Sharif M. Mansor, Christian P. Müller, Zurina Hassan, Zurina Hassan   +6 more
doaj   +1 more source

Differences in depression severity and frequency of relapses in opiate addicts treated with methadone or opiate blocker after detoxification [PDF]

Vojnosanitetski Pregled, 2012
Background/Aim. Relapse of opiate dependence is a common occurrence after detoxification and introduction of opiate addicts in abstinence from opiates. Clinical evaluation showed that over 90% of opiate addicts exhibit depressive manifestations during
Jovanović Tatjana, Lazarević Dušan, Nikolić Gordana   +2 more
doaj   +1 more source